Fundies.
English

Segment disclosures

Company overview

MIMEDX GROUP, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

4 dimension combinations 30 retained observations 10 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Regenerative Medicine Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=mdxg:RegenerativeMedicineSegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-300 USD20231030Open filing evidence
2023-01-01 – 2023-09-300 USD20231030Open filing evidence
2023-04-01 – 2023-06-300 USD20230801Open filing evidence
2023-01-01 – 2023-06-300 USD20230801Open filing evidence
2023-01-01 – 2023-03-310 USD20230502Open filing evidence
2022-07-01 – 2022-09-300 USD20231030Open filing evidence
2022-01-01 – 2022-09-300 USD20231030Open filing evidence
2022-04-01 – 2022-06-300 USD20230801Open filing evidence
2022-01-01 – 2022-06-300 USD20230801Open filing evidence
2022-01-01 – 2022-03-310 USD20230502Open filing evidence
2021-07-01 – 2021-09-3076000 USD20221102Open filing evidence
2021-01-01 – 2021-09-3016584000 USD20221102Open filing evidence

Operating Segments · Wound Surgical Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=mdxg:WoundSurgicalSegmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-3170629000 USD20230502Open filing evidence
2022-01-01 – 2022-03-3158330000 USD20230502Open filing evidence

Regenerative Medicine Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mdxg:RegenerativeMedicineSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-310 USD20230228Open filing evidence
2021-01-01 – 2021-12-3116596000 USD20230228Open filing evidence
2020-01-01 – 2020-12-3132362000 USD20230228Open filing evidence

Wound Surgical Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mdxg:WoundSurgicalSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-3080376000 USD20231030Open filing evidence
2023-01-01 – 2023-09-30231466000 USD20231030Open filing evidence
2023-04-01 – 2023-06-3080461000 USD20230801Open filing evidence
2023-01-01 – 2023-06-30151090000 USD20230801Open filing evidence
2022-01-01 – 2022-12-31264906000 USD20230228Open filing evidence
2022-07-01 – 2022-09-3066873000 USD20231030Open filing evidence
2022-01-01 – 2022-09-30191297000 USD20231030Open filing evidence
2022-04-01 – 2022-06-3066094000 USD20230801Open filing evidence
2022-01-01 – 2022-06-30124423000 USD20230801Open filing evidence
2021-01-01 – 2021-12-31238940000 USD20230228Open filing evidence
2021-07-01 – 2021-09-3062138000 USD20221102Open filing evidence
2021-01-01 – 2021-09-30172401000 USD20221102Open filing evidence
2020-01-01 – 2020-12-31213489000 USD20230228Open filing evidence